Acorda Therapeutics, Inc. - Company Profile and SWOT Analysis
Summary
Acorda Therapeutics, Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Acorda Therapeutics, Inc. (Acorda or 'the company') is involved in the identification, development and commercialization of novel therapies to treat neurological disorders. It is also engaged in the development and marketing of therapies to assist restore function in individuals with spinal cord injury, multiple sclerosis and related conditions of the central nervous system. The company also offers various pipeline products to neurological therapies including heart failure, migraine, Primary Sclerosing Cholangitis, MS, spinal cord injury and various other disorders. Acorda markets products under Zanaflex, Ampyra or Fampyra (dalfampridine); Inbrija, BTT1023 and GGF2 brands. It develops additional inhaled medicines for both systemic and pulmonary conditions. Acorda primarily operates in the US. The company is headquartered in Ardsley, New York, the US.
Scope
Detailed information on Acorda Therapeutics, Inc. required for business and competitor intelligence needs
A study of the major internal and external factors affecting Acorda Therapeutics, Inc. in the form of a SWOT analysis
An in-depth view of the business model of Acorda Therapeutics, Inc. including a breakdown and examination of key business segments
Intelligence on Acorda Therapeutics, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Acorda Therapeutics, Inc., such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of Acorda Therapeutics, Inc. and the factors that influence its strategies.
Track strategic initiatives of the company and latest corporate news and actions.
Assess Acorda Therapeutics, Inc. as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Acorda Therapeutics, Inc.'s business structure, strategy and prospects.